Drug Development

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

As contract manufacturers and drug companies meet at Informex, the stage is set for the latest in pharmaceutical chemical development.

Advances in Custom Synthesis

Angie Drakulich was editorial director of Pharmaceutical Technology.

FDA impersonators and counterfeit drugs threaten the public's trust in online pharmacies.

Is the Internet to Blame for Unsafe Drug Use?

A look at the formulation challenges in pancreatic enzyme products.

Specialty Pharmaceutical Focus: Pancreatic Enzyme Products

Sean Milmo is a freelance writer based in Essex, UK.

Regulators and industry move to require inspections of API manufacturing facilities.

In the Field: Report from Europe

When it comes to healthcare rform, we must not overlook investment in innovative technologies.

Innovation Today, Rewards Tomorrow

How to cut time and cost by re-using already submitted documents.

The eCTD Upgrade: Cross-Application Linking

Novartis CEO To Step Down; DSM To Close Netherlands Facility; And More.

Week Of Jan. 25, 2010: Company And People Notes: Novartis CEO To Step Down; DSM To Close Netherlands Facility; And More.

Lonza Group (Basel) plans to reinforce its presence in Asia, including its platform in Nansha, China, and to close its Conshohocken (Riverside), Pennsylvania; Shawinigan, Canada; and Wokingham, United Kingdom, sites in 2010.

Lonza Closes Sites in North America and UK

FDA Issues Warning Letter To McNeil Healthcare; Charles River Laboratories Will Suspend Operations At Massachusetts Facility.

Week Of Jan. 18, 2010: Company And People Notes: FDA Issues Warning Letter To McNeil Healthcare; Charles River Laboratories Will Suspend Operations At Massachusetts Facility; And More.

The United States Pharmacopeial Convention is recalling USP 33?NF 28.

Ingredients